News

Christopher Bunick, MD, PhD, shares pearls from his research in benzene contamination in sunscreens and what advice he shares with patients.

Leading clinicians discuss sun protection best practices based on weather, climate, and travel needs.

Leading clinicians discuss sun protection and special issues in photosensitivity.

Leading clinicians debunk 5 of the most common sunscreen myths.

Leading clinicians discuss sun protection best practices and recommendations for the upcoming summer months.

Patient adherence to self-management strategies can be difficult.

Elaine Kung, MD, FAAD, discusses advancements in energy-based devices and the ways physicians in the dermatology space can advance their standard of care for patients with skin of color.

Researchers investigated the effects of combination mesoderm therapy and compound glycyrrhizin injections in patients with rosacea.

Catch up on the innovative pearls shared at the 2023 American College of Mohs Surgery including strategies to enhace the patient experience, the role artificial intelligence plays in dermatologic care, and more.

In this week’s Pointers with Portela, the 208SkinDoc gives his best product recommendations for Mother's Day gifts.

In a large cohort of transgender patients, gender-affirming hormone therapy did not have an effect on the incidence of skin cancers.

Clinicians who provide dermatologic care know firsthand how diseases of the skin can diminish someone’s confidence and productivity.

When compared to a vehicle treatment, patients with rosacea being treated with oxymetazoline had a more significant reduction facial erythema.

In part 1 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.

Hamzavi spoke at the 2023 Pigmentary Disorder Exchange Symposium in Chicago.

Several dermatologic conditions are known to be associated with anxiety disorders or mental health concerns.

In this month's letter from the Editor in Chief, Zoe Diana Draelos, MD, discusses the latest advances and opportunities in the field of dermatology.

Researchers said doxycycline, however, was more efficacious in reducing inflammatory lesions.

More than 80% of medical assistants participating in the study said the new skill makes them feel more valuable.

Brandon Beal, MD shared his experience, which technology solutions work best, and resources available to dermatology practices.

The rapid pearl session explored a case that challenged surgeons to preserve the function of the tarsal plate and musculature attachments.

Reports project hiring for NPs, PAs, and dire situation for nursing across the nation.

The pigment disorder is associated with several autoimmune and systemic comorbidities.

Researchers compared counts between patients with vitiligo and a control group of patients.

Nicole Vélez, MD, provided marketing pearls to streamline mundane tasks and promote your practice in the digital world.

Researchers have identified what may be the first report of vitiligo induced de novo by dupilumab therapy.

His keynote speech at ACMS focused on artificial intelligence for precision medicine and cancer diagnosis.

Jerry Brewer, MD, MS, shared pearls on reasons to avoid or discontinue Mohs surgery and keeping calm with stressed, vulnerable patients.

Katie Schlenker, DO, emphasizes the importance of empathy during tough conversations with skin cancer patients with few to no treatment options left.

Collins said an office environment impacts outcomes and shared office design considerations.